Bumetanide

Product NDC
70518-2678
11-digit product format
705182678
Labeler code
70518
Product ID
70518-2678_d6e51f2a-2c8e-0554-e053-2a95a90a743c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Bumetanide
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA209724
Marketing category
ANDA
Marketing start
2020-04-08
Marketing end
0000-00-00
Substance
BUMETANIDE
Active strength
2 mg/1
Pharmacologic classes
Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2678-02022-01-31C16284748780-1d6a99b39-4911-a426-e053-dadaa90af4c247174ea7-be6d-4048-ac7b-e0ec2a1dbe69
70518-2678-02022-01-28C16284748780-1d6a99b39-4911-a426-e053-dadaa90af4c247174ea7-be6d-4048-ac7b-e0ec2a1dbe69

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2678-07051826780030 TABLET in 1 BLISTER PACK (70518-2678-0) 30 tablet2020-04-080000-00-00NoNoCurrent